Table 1.
Patients’ demographics of non-PAH subgroups and PAH subgroups
| non-PAH | PAH | ||||
|---|---|---|---|---|---|
| n = 12 | n = 5 | ||||
| Sex (M/F) | 11/1 | Sex (M/F) | 3/2 | ||
| Age (median, range) | 74.5 (57–83) | Age (median, range) | 77 (73–88) | ||
| Diagnosis | CVD-IP | 2 | Diagnosis | IIP | 1 |
| IIP | 1 | PAH | 1 | ||
| COPD | 4 | COPD | 2 | ||
| IP+COPD | 3 | Postoperation of lung cancer | 1 | ||
| Sarcoidosis | 1 | ||||
| NTM | 1 | ||||
| BNP (pg/ml) | 78.4 ± 52.2* | BNP (pg/ml) | 174.7 ± 186* | ||
| A-aDO2 (mmHg) | 46.9 ± 20.7 | A-aDO2 (mmHg) | 35.3 ± 21.6 | ||
| sPAP(UCG, mmHg) | 50.8 ± 19.3 | sPAP (UCG, mmHg) | 52.6 ± 16.6 | ||
| mPAP (RHC, mmHg) | 18.3 ± 3.7* | mPAP (RHC, mmHg) | 33.6 ± 7.0* | ||
| Data are presented as mean ± SD. | *:statistically significant (P values < 0.05). | ||||
A-aDO2, alveolar-arterial oxygen difference; BNP, brain natriuretic peptide; COPD, chronic obstructive pulmonary disease; CVD-IP, collagen vascular disease-interstitial pneumonia; F, female; IIP, idiopathic interstitial pneumonia; IP, interstitial pneumonia; M, male; NTM, nontuberculous mycobacteriosis; sPAP, systolic pulmonary arterial pressure; mPAP, mean pulmonary arterial pressure; PAH, pulmonary arterial hypertension; RHC, right heart catheterization; SD, standard deviation; UCG, ultrasound cardiography.